Ric Swindell

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Kay Kelly1
James Wylie1
Joanna Coote1
1Kay Kelly
1James Wylie
1Joanna Coote
Learn More
Background. The benefit of dose-escalated hypofractionated radiotherapy using intensity-modulated radiotherapy (IMRT) in prostate cancer is not established. We report 5-year outcome and long-term toxicity data within a phase II clinical trial. Materials and Methods. 60 men with predominantly high-risk prostate cancer were treated. All patients received(More)
  • 1